ArticleJournal of education and health promotion2025
Development and evaluation of a self-management mobile application for gastric cancer chemotherapy side effects.
Article in Journal of education and health promotion, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSelf-management is crucial for cancer patients undergoing chemotherapy to control and reduce side effects, thereby improving their quality of life. This study aimed to develop and evaluate a mobile application for the self-management of chemotherapy side effects in gastric cancer patients, leveraging the widespread use and capabilities of smartphones. MATERIALS AND
methodThis applied study identified the needs of gastric cancer patients undergoing chemotherapy through a review of scientific literature and consultations with patients and expert doctors. The application prototype was developed using Java for the Android platform. Patients used the application for 1 month, after which user satisfaction was evaluated using the Questionnaire for User Interaction Satisfaction version 5.5, the mHealth App Usability Questionnaire, and a researcher-made checklist.
resultsThe application features included patient profiles, side effect management, lifestyle guidance, and system capabilities. Services provided by the application included self-assessment tests for chemotherapy side effects, with analyses categorized into three warning levels (green, orange, and red). Additionally, the app provided alerts for daily self-assessment, medication reminders, therapy sessions, and daily lifestyle tips.
conclusionUser satisfaction with the application's functionality and capabilities was 98%, indicating a high level of acceptance. The self-management application can assist gastric cancer patients undergoing chemotherapy in managing side effects, adhering to a healthy diet and lifestyle, managing medication, learning self-management skills, and overall improving their lifestyle.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.